The Role of Iron in Neurodegeneration
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 14 (2) , 115-140
- https://doi.org/10.2165/00002512-199914020-00004
Abstract
Although the aetiology of Parkinson’s disease (PD) and related neurodegenerative disorders is still unknown, recent evidence from human and experimental animal models suggests that a misregulation of...Keywords
This publication has 95 references indexed in Scilit:
- Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging miceNeurochemical Research, 1995
- Glutamatergic drugs in Parkinson's diseaseLife Sciences, 1994
- Progressive Changes in Striatal Dopaminergic Markers, Nigral Volume, and Rotational Behavior Following Iron Infusion into the Rat Substantia NigraExperimental Neurology, 1994
- Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neuronsAnnals of Neurology, 1994
- An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's diseaseAnnals of Neurology, 1994
- Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated miceExperimental Neurology, 1991
- 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particlesBiochemical and Biophysical Research Communications, 1990
- Desferrioxamine as a lipid chain‐breaking antioxidant in sickle erythrocyte membranesFEBS Letters, 1990
- Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degenerationAnnals of Neurology, 1989
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988